Assignee
CLARUS THERAPEUTICS INC
US·9 granted patents·22 pending applications·58 citations·filing 2012–2021
Top patents by PatentIndex Score
31 records- 0196US11331325B2Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2019·Granted May 17, 2022·4 cites·6 claims
- 0296US8828428B1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2014·Granted Sep 9, 2014·19 cites·4 claims
- 0395US11179402B2Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Granted Nov 23, 2021·5 cites·17 claims
- 0495US11179403B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·5 cites·27 claims
- 0590US10617696B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2016·Granted Apr 14, 2020·5 cites·1 claims
- 0690US10543219B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Granted Jan 28, 2020·5 cites·12 claims
- 0790US8778917B2Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2013·Granted Jul 15, 2014·7 cites·9 claims
- 0888US11426416B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2019·Granted Aug 30, 2022·1 cites·9 claims
- 0982US10245273B2Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agentsCLARUS THERAPEUTICS INC·Filed 2014·Granted Apr 2, 2019·7 cites·11 claims
- 1072US2019070196A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1169US2018021350A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1269US2018028542A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1369US2018078566A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1469US2020197413A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1569US2014296199A1Pharmaceutical delivery systems for hydrophobic drugs and compositions compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1669US2020197412A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1769US2018021351A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1866US2022088034A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1965US2013022674A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2065US2014274986A1Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2165US2021220374A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2263US2015343073A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2363US2016000806A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2463US2015343074A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2563US2015343072A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2658US2020054648A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2757US2014303129A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2854US2020038411A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2953US2017246184A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3051US2018333423A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3149US2020016172A1Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agentsCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →